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MeBACKGROUND Obesity begets atrial ﬁbrillation (AF). Although cardiorespiratory ﬁtness is protective against incident
AF in obese individuals, its effect on AF recurrence or the beneﬁt of cardiorespiratory ﬁtness gain is unknown.
OBJECTIVES This study sought to evaluate the role of cardiorespiratory ﬁtness and the incremental beneﬁt of
cardiorespiratory ﬁtness improvement on rhythm control in obese individuals with AF.
METHODS Of 1,415 consecutive patients with AF, 825 had a body mass index $27 kg/m2 and were offered risk factor
management and participation in a tailored exercise program. After exclusions, 308 patients were included in the
analysis. Patients underwent exercise stress testing to determine peak metabolic equivalents (METs). To determine a
dose response, cardiorespiratory ﬁtness was categorized as: low (<85%), adequate (86% to 100%), and high (>100%).
Impact of cardiorespiratory ﬁtness gain was ascertained by the objective gain in ﬁtness at ﬁnal follow-up ($2 METs vs.
<2 METs). AF rhythm control was determined using 7-day Holter monitoring and AF severity scale questionnaire.
RESULTS There were no differences in baseline characteristics or follow-up duration between the groups deﬁned by
cardiorespiratory ﬁtness. Arrhythmia-free survival with and without rhythm control strategies was greatest in patients
with high cardiorespiratory ﬁtness compared to adequate or low cardiorespiratory ﬁtness (p < 0.001 for both). AF burden
and symptom severity decreased signiﬁcantly in the group with cardiorespiratory ﬁtness gain $2 METs as compared
to <2 METs group (p < 0.001 for all). Arrhythmia-free survival with and without rhythm control strategies was greatest
in those with METs gain $2 compared to those with METs gain <2 in cardiorespiratory ﬁtness (p < 0.001 for both).
CONCLUSIONS Cardiorespiratory ﬁtness predicts arrhythmia recurrence in obese individuals with symptomatic AF.
Improvement in cardiorespiratory ﬁtness augments the beneﬁcial effects of weight loss. (Evaluating the Impact of a
Weight Loss on the Burden of Atrial Fibrillation [AF] in Obese Patients; ACTRN12614001123639) (J Am Coll Cardiol
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ABBR EV I A T I ON S
AND ACRONYMS
AF = atrial ﬁbrillation
AFSS = Atrial Fibrillation
Severity Scale
BMI = body mass index
BP = blood pressure
HR = hazard ratio
METs = metabolic equivalents
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986A trial ﬁbrillation (AF) is a growingepidemic affecting approximately33.5 million individuals worldwide
(1,2). Cardiac risk factors such as obesity
are associated with increased risk of AF
and could explain this rising epidemic (3).
Several lifestyle factors, including a lack
of physical activity, are associated with
increased incidence of obesity (4).
Lifestyle modiﬁcation with weight loss has
been shown to reduce AF burden (5). In the Long-
Term Effect of Goal-Directed Weight Management in
an Atrial Fibrillation Cohort: A Long-Term Follow-Up
Study (LEGACY), progressive weight loss had a
dose-dependent effect on long-term AF freedom (6).
Increasing physical activity to enhance cardiorespi-
ratory ﬁtness is an integral component of lifestyle
modiﬁcation. Cardiorespiratory ﬁtness is an inde-
pendent predictor of cardiovascular outcome and
mortality (7). Recent studies have found an inverse
relationship between increased physical activity and
the risk of incident AF (8,9), but the impact of
cardiorespiratory ﬁtness on risk of AF recurrence has
not been examined previously. Furthermore, longi-
tudinal improvement in cardiorespiratory ﬁtness is
associated with a lower risk of both all-cause and
cardiovascular mortality (10). However, the impact of
cardiorespiratory ﬁtness gain with a graded exercise
program along with weight loss on AF outcome re-
mains unclear and is largely neglected as a thera-
peutic target.SEE PAGE 997We hypothesize that preserved cardiorespiratory
ﬁtness at baseline in obese AF patients offsets some
of the detrimental effects of obesity and that gain in
cardiorespiratory ﬁtness through a structured exer-
cise program has synergistic effect with weight loss
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STUDY POPULATION. This study comprised patients
referred for management of symptomatic paroxysmal
or persistent AF to the Centre for Heart Rhythm
Disorders at the University of Adelaide, Adelaide,
Australia. All patients with a body mass index
(BMI) $27 kg/m2 and undergoing an exercise stress
test at baseline were included in this analysis.
Exclusion criteria were: permanent AF; history of
myocardial infarction or cardiac surgery in the pre-
vious 12 months; active malignancy; autoimmune or
systemic inﬂammatory diseases; severe renal or he-
patic failure; left ventricular ejection fraction <40%;
pacemaker in situ; and <24-months of follow-up. In
addition, patients who were in AF or could not
perform exercise stress test because of neuromus-
cular or musculoskeletal problems were excluded.
All patients provided written informed consent.
The Human Research Ethics Committee of the Royal
Adelaide Hospital and University of Adelaide ap-
proved the study protocol.
STUDY PROTOCOL AND DESIGN
WEIGHT AND RISK FACTOR MANAGEMENT. All pa-
tients were offered attendance at a dedicated
physician-led risk factor management clinic at the
time of initial assessment. The weight and risk factor
management protocol used in our service has been
presented previously (6). In brief, a structured moti-
vational, individualized, goal-directed program using
face-to-face counseling was used for initiating and
reinforcing graded exercise therapy along with
weight reduction. Initial weight loss was attempted
by a meal plan and behavior modiﬁcation. Meals
consisted of high protein and low glycemic index,
calorie-controlled foods. Hypertension, glucose in-
tolerance, dyslipidemia, sleep apnea, and alcohol
and tobacco use were screened for and managedfrom the University of Adelaide. Dr. Mahajan has
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987individually according to American Heart Association/
American College of Cardiology guidelines. Changes
in metabolic (lipid proﬁle and fasting insulin) and in-
ﬂammatory state (high-sensitivity C-reactive protein
[hsCRP]) levels were monitored.
EXERCISE PROGRAM. Patients were recommended
structured physical activity according to American
Heart Association guidelines (11). A baseline exercise
stress test was used to ascertain cardiorespiratory
ﬁtness. Subsequently, a tailored exercise program
was designed in which consideration for age and
physical ability was made so that targets were
achievable without risking injuries. The frequency,
intensity, time [duration], and type of exercise
principle was used to design a combination of aero-
bic and resistance/strength exercises for progressive
ﬁtness gain to avoid weight plateaus. Low-intensity
exercise was prescribed initially for 20 min 3 times
weekly increasing to at least 200 min of moderate-
intensity exercise per week. For patients with
decreased mobility because of weight and or
musculoskeletal problems, hydrotherapy, aqua aer-
obics, upper body training, and physiotherapy ses-
sions were initially used. Participants were advised
to use a wearable heart rate monitor and were
required to maintain a diet and physical activity
diary to log exercise type, frequency, intensity,
and duration. After calculating their maximal heart
rate (220  age), patients were advised to avoid
reaching heart rate >85% of the maximal predicted
heart rate.
ASSESSMENT OF CARDIORESPIRATORY FITNESS.
Cardiorespiratory ﬁtness was evaluated in sex-speciﬁc
metabolic equivalents (METs) estimated from a
symptom-limited maximal treadmill exercise test us-
ing the standard Bruce protocol at baseline and ﬁnal
follow-up. The test time using this protocol on the
treadmill was recorded. If patients achieved only a
fraction of the stage of exercise, credit for exercise
capacity was “pro-rated.” Test time was then used
to calculate METs (12). Age- and sex-predicted peak
METs were calculated using the St. James model
(METs ¼ 14.7  [0.13  age]) for women and the
Veterans Affairs referral model (METs ¼ 18  [0.15 
age]) for men (13).
DEFINITIONS. Baseline cardiorespiratory ﬁtness. Study
patients were subsequently categorized according to
baseline cardiorespiratory ﬁtness into low (<85%
predicted METs), adequate (86% to 100% predicted
METs), and high (>100% predicted METs) cardiore-
spiratory ﬁtness groups (13).
Card ioresp i ratory ﬁ tness ga in . To investigate the
change in cardiorespiratory ﬁtness on AF outcome,we dichotomized ﬁtness gain into a METs gain $2 and
a METs gain <2 at ﬁnal follow-up.
Weight loss and card ioresp i ratory ﬁ tness ga in
interact ion . We have previously demonstrated ef-
fect of weight loss on AF outcome (6). As was pre-
sented, no weight loss was deﬁned as <3% weight
loss and signiﬁcant weight loss as $10% weight loss.
To investigate the interaction between weight loss
and METs gain, we divided patients into group 1
(<10% weight loss and <2 METs gain), group 2 (<10%
weight loss and $2 METs gain), group 3 ($10% weight
loss and <2 METs gain), and group 4 ($10% weight
loss and $2 METs gain).
ARRHYTHMIA MANAGEMENT. AF management was
undertaken in a separate arrhythmia clinic. The use of
rate and rhythm control strategies was at the discre-
tion of the treating physician. In patients who
remained symptomatic despite the use of antiar-
rhythmic agents, AF ablationwas offered. The ablation
technique used at our institution has been previously
described and is outlined in the Online Appendix (14).
AF was determined at least annually by clinical re-
view, 12-lead electrocardiogram, and 7-day Holter
monitoring. In patients undergoing ablation, proce-
dural success was determined after a 3-month blank-
ing period. AF was taken as any atrial arrhythmia $30
s. If patients developed recurrent arrhythmia after
the blanking period (3 months), repeat ablation was
offered. The earliest date with documented AF was set
as the date of arrhythmia recurrence. Only conﬁrmed
events were included in the analyses. All patients were
anticoagulated if the CHADS2 (measuring congestive
heart failure, hypertension, age, diabetes mellitus
[DM], and prior stroke) score >1.
Cardiac structural parameters were monitored by
serial echocardiographic examinations. All echocar-
diographic and rhythm evaluations are detailed in the
Online Appendix and were performed by operators
blinded to the patient’s weight and ﬁtness manage-
ment regimen.
OUTCOMES. The primary outcome was AF burden as
determined by symptom burden and freedom from
AF. AF symptom burden was determined by the AF
Severity Scale (AFSS, University of Toronto, Canada)
that quantitates 3 domains of AF-related symptoms:
frequency, duration, and severity (15). The AFSS has
been clinically validated and used for assessment of
AF burden (5,16). In addition, it provides a symptom
subscale and global well-being score. The AFSS
questionnaire was administered at baseline and ﬁnal
follow-up. Freedom from AF was ascertained with
7-day Holter monitoring. Secondary outcomes in-
cluded structural parameters of left atrial volume, left
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988ventricular wall thickness, and diastolic function
from echocardiographic studies.
STATISTICAL ANALYSIS. Categorical variables are
represented by frequencies and percentages. Con-
tinuous variables are summarized by mean  SD.
The differences in baseline characteristics between
groups were assessed using analysis of variance pro-
cedures for continuous variables and chi-square
for categorical variables. A repeated measure anal-
ysis of variance was used to assess change over
time. For categorical variables, change in status at
follow-up was compared between groups using a
chi-square test. Time-to-recurrence and event-free
survival curves after the last ablation procedure
were estimated by the Kaplan-Meier product-limit
method. Differences between curves were tested
with the log-rank test. Predictors of recurrent AF
were assessed using proportional hazards Cox
regression models. Candidate variables with p < 0.1 in
univariate analyses were considered in multivariate
regression models. Two-tailed p < 0.05 was consid-
ered statistically signiﬁcant. Statistical analysis was
performed with SPSS, version 21.0 (SPSS, Inc.,
Chicago, IL).FIGURE 1 Patient Selection
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Flow diagram demonstrating patient recruitment and attrition. AF ¼ atr
CRF ¼ cardiorespiratory ﬁtness; Dx ¼ disease; EST ¼ exercise stress tesRESULTS
Of 1,415 patients with symptomatic AF, 825 had a
BMI $27 kg/m2. Only patients who did not meet
exclusion criteria, had regular follow-up, and under-
went stress testing were included in the analysis.
Patients were excluded for: predeﬁned criteria
(n ¼ 303); interstate patients (n ¼ 177); premature
termination of test because of a musculoskeletal
problem (n ¼ 8); beta-blocker or calcium channel
blocker use on the day of procedure (n ¼ 16); or those
with AF on the exercise stress test (n ¼ 13) (Figure 1).
The ﬁnal cohort included 308 patients with a mean
follow-up of 49  19 months.
BASELINE CARDIORESPIRATORY FITNESS. The
characteristics of each group are shown in Table 1.
Ninety-ﬁve patients had low, 134 had adequate, and
79 had high cardiorespiratory ﬁtness at baseline.
Mean METs achieved in the low cardiorespiratory
ﬁtness group were 5.2  1.6, in the adequate cardio-
respiratory ﬁtness group 7.9  1.6, and in the high
cardiorespiratory ﬁtness group 8.8  1.7 (p ¼ 0.008).
Mean duration of follow-up was 47  18.3, 48  17,
and 48.2  18 months, respectively (p ¼ 0.8).<2 MET Gain
N = 181
≥2 MET Gain
N = 127
r Eligibility
,415
th BMI ≥27
825
ohort
308
CRF Gain
N = 308
Musculoskeletal Problem (N = 8)
Negative Chronotropic Drug (N = 16)
AF on the Day of EST (N = 13)
Patients From Other States (N = 177)
Met Exclusion Criteria (N = 303)
Terminal Cancer (N = 10)
Inflammatory Dx (N = 20)
Permanent AF (N = 84)
AV Node Ablation (N = 12)
AF Ablation (N = 90)
Severe Medical Illness (N = 77)
Pacemaker In-Situ (N = 10)
ial ﬁbrillation; AV ¼ atrioventricular; BMI ¼ body mass index;
t; MET ¼ metabolic equivalent.
TABLE 1 Baseline Characteristics for Baseline Cardiorespiratory Fitness Groups
Low CRF
(<85%)
(n ¼ 95)
Adequate CRF
(86% to 100%)
(n ¼ 134)
High CRF
(>100%)
(n ¼ 79) p Value
Age, yrs 58  13 56  10 69  9 0.10
Male 46 (49) 64 (48) 40 (51) 0.20
Follow-up duration, months 47  18.3 48  17.0 48.2  18.0 0.80
Anthropometric measures
BMI, kg/m2 34.0  4.8 32.7  4.5 32.8  5.1 0.08
SBP, mm Hg 145  16 144  18 149  18 0.10
Atrial ﬁbrillation
Paroxysmal AF 46 (48) 69 (52) 49 (62) 0.18
Nonparoxysmal 49 (52) 65 (48) 30 (38)
Metabolic risk factors
Hypertension 73 (77) 98 (73) 61 (78) 0.67
DM 32 (34) 34 (25) 18 (23) 0.28
IGT 5 (5) 13 (10) 10 (13)
Hyperlipidemia 38 (41) 51 (38) 31 (40) 0.40
Coronary artery disease 17 (18) 12 (9) 10 (13) 0.14
Valvulopathy 5 (5) 5 (4) 5 (6) 0.68
AHI >30 47 (49) 76 (57) 40 (51) 0.50
Alcohol excess (>30 g/week) 27 (28) 48 (36) 21 (27) 0.29
Smoker 8 (8) 47 (35) 20 (25) 0.06
Medication use
Mean number of AAD 1.0  0.7 0.9  0.7 0.9  0.7 0.34
Mean number of anti-HTN 0.9  1.1 0.7  0.7 0.8  0.9 0.19
Serology and lipid proﬁle
hsCRP, mg/L 4.4  6.0 4.9  11.9 4.8  7.6 0.95
Fasting insulin level, U 14.9  6.6 16.4  6.9 16.0  6.0 0.54
LDL level, mmol/l 2.7  1.0 2.9  0.8 3.0  1.0 0.22
TG level, mmol/l 1.6  0.5 1.7  0.8 1.5  0.7 0.45
Echocardiographic measures
LA volume index, ml/m2 38.9  3.8 38.1  5.4 39.4  6.4 0.21
IVS, mm 1.2  0.2 1.2  0.2 1.1  0.2 0.10
LVEDD, cm 5.0  0.6 5.0  0.5 4.9  0.6 0.37
E/E’ ratio 11.9  3.5 11.4  4.1 13.0  4.8 0.06
AFSS
Frequency (scale: 1-10) 6.9  1.8 7.0  1.6 7.3  1.2 0.28
Duration (scale: 1-10) 6.8  1.9 7.1  1.8 6.6  1.7 0.17
Severity (scale: 1-10) 6.7  1.4 6.9  1.9 7.1  1.8 0.47
Symptom (scale: 0-35) 17.6  5.5 18.0  5.5 19.6  5.8 0.07
Global well-being (scale: 1-10) 2.7  0.8 2.4  0.9 2.5  0.9 0.4
Values are mean  SD or n (%).
AAD ¼ antiarrhythmic drug; AF ¼ atrial ﬁbrillation; AFSS ¼ Atrial Fibrillation Severity Scale; anti-HTN ¼
antihypertensive medication; AHI ¼ Apnea Hypopnea Index; BMI ¼ body mass index; CRF ¼ cardiorespiratory
ﬁtness; DM¼ diabetes mellitus; hsCRP¼ high-sensitivity C-reactive protein; HTN ¼ hypertension; IGT ¼ impaired
glucose tolerance; IVS ¼ interventricular septum; LA ¼ left atrium; LDL ¼ low-density lipoprotein; LVEDD ¼ left
ventricular end-diastolic diameter; SBP ¼ systolic blood pressure; TG ¼ triglyceride.
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989EFFECT OF BASELINE CARDIORESPIRATORY FITNESS
ON AF OUTCOMES. Freedom from AF without the
use of rhythm contro l s t rateg ies . Figure 2A dem-
onstrates “ablation- and drug-free” AF freedom. At
ﬁnal follow-up, 12% of the low, 35% of the adequate,
and 66% of the high cardiorespiratory ﬁtness group
(p < 0.001) remained free from arrhythmia without
antiarrhythmic drugs or ablation. Univariate pre-
dictors of AF recurrence were as follows: cardiore-
spiratory ﬁtness group (p < 0.001), no weight loss
group (p ¼ 0.001), and left ventricular hypertrophy
group (p ¼ 0.05). On multivariable analysis, the
cardiorespiratory ﬁtness group (compared with the
high cardiorespiratory ﬁtness and low cardiorespira-
tory ﬁtness groups: HR: 2.75; 95% CI: 1.61 to 4.68;
adequate cardiorespiratory ﬁtness: HR: 1.89; 95% CI:
1.14 to 3.12; p ¼ 0.001), no weight loss (HR: 2.95; 95%
CI: 1.8 to 4.8) remained an independent predictor of
AF recurrence. Each unit increase in METs of baseline
cardiorespiratory ﬁtness was associated with a 13%
decline in the risk of AF recurrence (HR: 0.87; 95% CI:
0.80 to 0.94; p < 0.001), even after adjusting for
weight loss during follow-up.
Tota l ar rhythmia- f ree surv iva l . Figure 2B demon-
strates the total arrhythmia-free survival with signif-
icant attrition in the low cardiorespiratory ﬁtness
group compared with the adequate and high cardio-
respiratory ﬁtness groups. At ﬁnal follow-up, total
arrhythmia-free survival rates was 17% in the low,
76% in the adequate, and 84% in the high cardiore-
spiratory ﬁtness groups (p < 0.001). Univariate pre-
dictors of AF recurrence were: cardiorespiratory
ﬁtness group (p < 0.001), no weight loss (p < 0.001),
DM (p ¼ 0.01), and smoking status (p ¼ 0.04).
On multivariable analysis, the low cardiorespiratory
ﬁtness but not the adequate cardiorespiratory ﬁtness
(compared with the high cardiorespiratory ﬁtness and
low cardiorespiratory ﬁtness groups: HR: 5.94; 95%
CI: 3.15 to 11.23; p < 0.001; adequate cardiorespiratory
ﬁtness group: HR: 1.17; 95% CI: 0.60 to 2.26; p < 0.65)
and no weight loss group (HR: 3.64; 95% CI: 1.95 to
6.76) remained an independent predictor of AF
recurrence. For cardiorespiratory ﬁtness expressed as
a continuous variable, even after adjusting for weight
loss during follow-up, there was a 20% reduction in
total arrhythmia recurrence for each additional MET
achieved during baseline cardiorespiratory ﬁtness
assessment (HR: 0.80; 95% CI: 0.74 to 0.87; p < 0.001).
CARDIORESPIRATORY FITNESS GAIN. Cardiorespir-
atory ﬁtness gain was 2.9  0.9 versus 0.5  1.4 METs
in the $2 METs and <2 METs gain groups, respec-
tively (p < 0.001). This corresponded with higher
participation in the dedicated risk factor managementclinic (83% in the $2 METs gain vs. 39% in the <2
METs gain group; p < 0.001). The characteristics of
both groups are shown in Table 2.
EFFECT OF CARDIORESPIRATORY FITNESS GAIN ON
RISK FACTOR PROFILE. Table 3 shows the impact of
cardiorespiratory ﬁtness gain on various cardiac risk
factors.
Weight loss . Weight decreased in both groups, but
signiﬁcantly more in patients who gained $2 METs
FIGURE 2 AF Freedom Outcome According to Baseline Cardiorespiratory Fitness (Baseline METs Achieved)
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990compared with those with <2 METs gain (12  8.8
vs. 3  7.6 kg; p ¼ 0.001). Additionally, the $2 METs
gain group had more sustained weight loss compared
to the <2 METs gain group (54% vs. 46%; p ¼ 0.006),
and fewer patients ﬂuctuated >5% in their weight
during the yearly follow-up (37% vs. 63%; p ¼ 0.001).
Blood pressure contro l . There was a greater decline
in systolic blood pressure (BP) in patients who
gained$2 METs compared to those with a<2 MET gain
(14  16.4 vs. 10  18 mm Hg; p ¼ 0.05). The number of
antihypertensive agents used for BP control decreased
in patients with a $2 METs gain (0.8  0.8 to 0.5  0.5;
p ¼ 0.01) and remained unchanged in those with a <2
METs gain (0.8  1.0 to 0.9  0.7; p ¼ 0.2).
L ip id proﬁ le . At baseline, 46% of the $2 METs and
48% of the <2 METs gain groups had dyslipidemia
(p ¼ 0.7). Drug therapy was required in 29% and 35%
of patients in each group, respectively (p < 0.001).
Both low-density lipoprotein cholesterol and plasma
triglycerides declined signiﬁcantly in patients who
gained $2 METs (p < 0.001), but did not differ in
those with a <2 METs gain.
GLYCEMIC CONTROL. At baseline, 29% of the
$2 METs and 25% of the <2 METs gain groups hada history of DM (p ¼ 0.8). At ﬁnal follow-up, DM
patients in the $2 METs group had a signiﬁcantly
better glycemic control compared to those in the
<2 METs gain group (glycated hemoglobin <7% in
12% vs. 3%, respectively; p ¼ 0.001).
Inﬂammat ion . Patients with a $2 METs gain
demonstrated a decrease in mean hsCRP (p < 0.001)
from baseline to follow-up. There was no change in
hsCRP in patients with a <2 METs gain (p ¼ 0.8).
EFFECT OF CARDIORESPIRATORY FITNESS GAIN ON
CARDIAC STRUCTURE. Table 3 shows the effect of
cardiorespiratory ﬁtness gain on cardiac structure.
The left atrial volume indexed for body surface area
decreased signiﬁcantly in both groups. There was a
greater decline in left atrial volume index with a $2
METs gain (p < 0.001). A similar trend was seen in left
ventricular end-diastolic diameter, in which a $2
METs gain corresponded to greater reductions in left
ventricular end-diastolic diameter. Lateral E/E0
declined in patients with a $2 METs gain, but did not
change in the <2 METs gain group.
EFFECT OF CARDIORESPIRATORY FITNESS GAIN ON
AF SYMPTOM BURDEN. At baseline, both groups had
comparable and high AFSS subscale scores (Table 3).
TABLE 2 Baseline Characteristics for CRF Gain Groups
<2 METs Gain
(n ¼ 181)
$2 METs Gain
(n ¼ 127) p Value
Age, yrs 58  11 59  12 0.40
Male 118 (65) 87 (69) 0.54
Follow-up duration, months 48.0  18.0 47.6  17.1 0.72
CRF gained, METs 0.5  1.4 2.9  0.9 <0.001
Anthropometric measures
Weight, kg 101  17 99  16 0.36
BMI, kg/m2 33.4  5.0 32.7  4.5 0.20
SBP, mm Hg 146  18 145  17 0.71
AF
Paroxysmal AF 99 (54) 66 (52) 0.67
Nonparoxysmal 82 (46) 61 (48)
Metabolic risk factors
Hypertension 140 (78) 92 (72) 0.28
DM 52 (29) 32 (25) 0.79
IGT 16 (9) 12 (9)
Dyslipidemia 87 (48) 58 (46) 0.65
Coronary artery disease 25 (14) 14 (11) 0.49
Valvulopathy 8 (4) 7 (6) 0.66
AHI >30 90 (50) 73 (57) 0.18
Alcohol excess (>30 g/week) 90 (50) 73 (57) 0.55
Smoker 12 (7) 3 (2) 0.22
Medication use
% on beta-blocker or CCB 72 (40) 54 (43) 0.82
Mean number of AAD 0.9  0.7 0.9  0.6 0.90
Mean number of anti-HTN 0.8  1.0 0.8  0.8 0.88
Serology and lipid proﬁle
Mean hsCRP, mg/l 4.8  9.7 4.6  9.0 0.91
Mean fasting insulin level, U 15.7  6.9 16.2  6.1 0.67
Mean LDL level, mmol/l 2.8  1.0 2.9  0.9 0.38
Mean TG level, mmol/l 1.6  0.7 1.6  0.6 0.90
Echocardiographic measures
LA volume indexed, ml/m2 39.2  4.6 38.0  6.0 0.08
IVS, mm 1.1  0.3 1.0  0.2 0.9
LVEDD, cm 5.1  0.6 5.0  0.4 0.5
Lateral E/E’ ratio 11.7  3.5 12.5  4.8 0.10
AFSS
Frequency (scale: 1-10) 7.2  1.5 6.8  1.6 0.50
Duration (scale: 1-10) 6.8  1.8 7.0  1.8 0.48
Severity (scale: 1-10) 6.8  1.6 7.0  1.8 0.51
Symptom (scale: 0-35) 17.9  5.4 18.7  5.8 0.25
Global well-being (scale: 1-10) 2.5  0.9 2.4  0.9 0.9
Values are mean  SD or n (%).
CCB ¼ calcium-channel blocker; METs ¼ metabolic equivalents; other abbreviations as in Table 1.
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991AF frequency, duration, symptom, and symptom
severity were reduced at ﬁnal follow-up in both
groups, with a signiﬁcantly greater reduction seen in
the $2 METs gain group (p < 0.001).
Freedom from AF without the use of rhythm
control s t rateg ies . Figure 3A demonstrates the
“ablation- and drug-free” AF freedom based on METs
gain groups. At ﬁnal follow-up, 61% of patients who
gained $2 METs remained free from arrhythmia
without antiarrhythmic drugs or ablation compared
to 18% of patients in the <2 METs gain group. Change
in cardiorespiratory ﬁtness was a signiﬁcant univari-
ate predictor of AF recurrence (p < 0.001). On multi-
variable analysis, a <2 METs gain (HR: 2.1; 95% CI 1.3
to 3.3; p ¼ 0.001), no weight loss (HR: 1.7; 95% CI 1.0
to 3.1; p ¼ 0.005), and low baseline cardiorespiratory
ﬁtness (HR: 2.7; 95% CI 1.57 to 4.52; p < 0.001)
remained independent predictors of AF recurrence.
As a continuous variable, every METs gained from
baseline to follow-up was associated with a 9%
decline in the risk of arrhythmia recurrence even after
adjustment for weight loss and baseline cardiorespi-
ratory ﬁtness (HR per 1-MET change: 0.90; 95% CI:
0.83 to 1.00; p ¼ 0.036).
Tota l a r rhythmia- f ree surv iva l . Figure 3B dem-
onstrates the total arrhythmia-free survival for the
2 groups. At ﬁnal follow-up, patients who gained
$2 METs had higher arrhythmia-free survival rates
compared to patients who gained <2 METs (89% vs.
40%; p < 0.001). Change in cardiorespiratory ﬁtness
was a signiﬁcant univariate predictor of AF recur-
rence (p<0.001). Onmultivariable analysis, a<2METs
gain (HR: 3.9; 95% CI: 2.1 to 7.3; p < 0.001), no weight
loss (HR: 1.9; 95% CI: 1.1 to 3.70; p ¼ 0.008), low
baseline cardiorespiratory ﬁtness (HR: 5.12; 95% CI:
2.67 to 9.84; p < 0.001), and DM (HR: 1.77; 95% CI:
1.2 to 2.6; p ¼ 0.003) remained independent pre-
dictors of AF recurrence. As a continuous variable,
every MET gained from baseline to follow-up was
associated with a 12% decline in the risk of total
arrhythmia recurrence after multivariate adjustment
(HR 1-MET change: 0.88; 95% CI: 0.80 to 0.96;
p ¼ 0.005).
WEIGHT LOSS AND CARDIORESPIRATORY FITNESS
GAIN INTERACTION: SYNERGISTIC EFFECT. A total
of 152 patients had <10% weight loss and <2 METs
gain (group 1), 49 had <10% weight loss and $2
METs gain (group 2), 29 had $10% weight loss
with <2 METs gain (group 3), and 78 had $10% weight
loss with $2 METs gain (group 4). Cardiorespiratory
ﬁtness gain provides additional beneﬁt above that
conferred by weight loss alone. Figure 4A demon-
strates the “ablation- and drug-free” AF freedom forthe 4 groups. At ﬁnal follow-up, 13.2% of group 1,
36.7% of group 2, 44.8% of group 3, and 75.6%
of group 4 (p < 0.001) remained free from
arrhythmia without antiarrhythmic drugs or abla-
tion. Figure 4B demonstrates the total arrhythmia-
free survival for the 4 groups. At ﬁnal follow-up,
34% of group 1, 69% of group 2, 81% of group 3,
and 94% of group 4 (p < 0.001) remained free
from arrhythmia.
TABLE 3 Cardiorespiratory Fitness Gain
Risk Factors
<2 METs Gain Group
(N ¼ 181)
$2 METs Gain Group
(N ¼ 127)
p Value†Baseline Follow-Up‡ p Value* Baseline Follow-Up‡ p Value*
Weight, kg 101  17 98  19 <0.001 99  16 87  14 <0.001 <0.001
BMI, kg/m2 33.5  5.0 32.5  5.3 <0.001 32.7  4.5 28.8  4.2 <0.001 <0.001
Mean SBP, mm Hg 146  18 136  14 <0.001 145  17 131  13 <0.001 0.047
DM with HbA1c $7 40 (22) 21 (12) 30 (24) 4 (3) <0.001
Medication use
Mean number of anti-HTN, n 0.8  1.0 0.9  0.7 0.20 0.8  0.8 0.5  0.5 0.001 <0.001
On lipid Rx 68 (38) 63 (35) 51 (40) 36 (29) <0.001
Mean number of AAD 0.9  0.7 0.4  0.6 <0.001 0.9  0.7 0.2  0.5 <0.001 0.04
Serology and lipid proﬁle
Mean hsCRP, mg/l 4.1  5.9 3.9  4.5 0.75 4.6  9.0 1.6  2.7 <0.001 0.02
Mean fasting insulin level, U 15.9  6.8 15.3  10.2 0.54 16.6  5.9 9.5  4.7 <0.001 <0.001
Mean LDL level, mmol/l 2.8  1.0 2.7  0.8 0.09 3.0  0.8 2.3  0.7 <0.001 <0.001
Mean TG level, mmol/l 1.6  0.7 1.5  0.7 0.22 1.6  0.6 1.2  0.5 <0.001 <0.001
Echocardiogram
Indexed LA volume, ml/m2 39.1  4.6 37.9  6.8 0.03 38.0  6.0 32.0  9.5 <0.001 <0.001
IV septum, mm 1.1  0.3 1.1  0.2 0.7 1.0  0.2 0.9  0.1 0.02 0.01
LVEDD, cm 5.1  0.6 4.9  0.6 0.01 5.0  0.4 4.7  0.8 <0.001 0.01
Lateral E/E’ ratio 11.7  3.5 11.4  5.0 0.55 12.5  4.8 8.7  3.3 <0.001 <0.001
AFSS
AF frequency (scale: 1-10) 7.2  1.4 4.3  1.8 <0.001 6.8  1.6 2.8  1.6 <0.001 <0.001
AF duration (scale: 1.25-10) 6.8  1.8 5.4  2.3 <0.001 7.0  1.8 3.9  2.2 <0.001 <0.001
AF episode severity (scale: 1-10) 6.9  1.6 4.7  2.0 <0.001 6.9  1.7 3.6  1.7 <0.001 <0.001
AF symptom subscale (scale: 0-35) 18.2  5.1 12.2  5.1 <0.001 18.8  5.9 9.1  4.6 <0.001 <0.001
Global well-being (1-10) 2.5  0.9 5.7  2.0 <0.001 2.4  0.9 7.6  1.7 <0.001 <0.001
Values are mean  SD or n (%). Impact of cardiorespiratory ﬁtness gain on cardiac risk factors, cardiac structure, and AF severity from baseline to follow-up. *p value refers to
within group difference (baseline to follow-up). †p value refers to between group differences over time (group-time interaction). ‡Median follow-up: 48.0  18.0 months
for <2 METs gain group and 47.6  17.1 months for $2 METs gain group.
HbA1c ¼ glycated hemoglobin; Rx ¼ prescription; other abbreviations as in Tables 1 and 2.
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992DISCUSSION
This study demonstrates that in overweight and
obese individuals with symptomatic AF, preserved
baseline cardiorespiratory ﬁtness predicts long-term
freedom from AF. We found a signiﬁcant dose-
response relationship between baseline cardiore-
spiratory ﬁtness with a 20% reduction in the risk of
AF recurrence for each MET increase in baseline
cardiorespiratory ﬁtness. Cardiorespiratory ﬁtness
gain with a structured exercise program (Central
Illustration) has an additive effect to weight loss in
improving the long-term outcome of AF. METs gain
in cardiorespiratory ﬁtness $2 on top of weight loss
were associated with 2-fold greater freedom from AF.
Speciﬁcally, participation in a dedicated risk factor
management clinic was associated with increased
cardiorespiratory ﬁtness gain. These ﬁndings high-
light the prescriptive role of exercise in managing
patients with AF, particularly as a strategy for rhythm
control.Several population-based studies have demon-
strated a robust relationship between obesity and AF
(3). Modiﬁers of this association such as weight loss
have been shown to reduce AF recurrence (6,16).
Physical activity has previously been suggested to
mitigate some of the cardiovascular hazards associ-
ated with excess body weight (17,18). However, the
relationship between physical activity and AF is
highly contentious (18,19) because it is mostly based
on the results from population-based longitudinal
studies with self-reported data (18,20). Recent studies
have suggested that increased leisure time physical
activity may be protective against AF even in the
presence of obesity (8,21). In the current study, we
used objective measures of cardiorespiratory ﬁtness
to demonstrate the prognostic beneﬁts in patients
with symptomatic AF. This remains signiﬁcant even
after adjustment for change in BMI observed
throughout the follow-up. Our results suggest that
cardiorespiratory ﬁtness may partially offset the
adverse effects of obesity.
FIGURE 3 Outcomes of AF Freedom According to Cardiorespiratory Fitness Gain (<2 METs Gain vs. $2 METs Gain)
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(A) Kaplan-Meier curve for total AF-free survival (multiple ablation procedures  drugs) according to weight trend. (B) Kaplan-Meier curve for total AF-free
survival (multiple ablation procedures  drugs) according to weight ﬂuctuation. Abbreviations as in Figure 1.
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993Few studies have examined the role of exercise
training per se on arrhythmia burden in those with
symptomatic AF. Short-term exercise intervention
has been shown to improve health-related quality
of life and exercise capacity in patients with per-
manent AF (22,23). In the present study, a gain
in cardiorespiratory ﬁtness ($2 METs) associated
with a reduction in AF burden marked improvement
in long-term freedom from AF. Indeed, 61% previ-
ously symptomatic AF patients no longer required
antiarrhythmic medications or ablation. We observed
a 9% gain in long-term freedom from AF for each
unit gain in METs. This gain is independent from
the beneﬁt conferred by weight loss alone in these
patients. The seminal ﬁnding that the change in
cardiorespiratory ﬁtness over a follow-up period re-
duces AF recurrence supports a possible role for the
prescription of exercise in this cohort. Notably,
participation in a dedicated risk factor management
clinic was associated with a greater increase in
cardiorespiratory ﬁtness.
Obesity is associated with various electrical and
structural remodeling leading to genesis and
perpetuation of AF (24–26). Our prior workdemonstrated that weight loss has a beneﬁcial ef-
fect on cardiac risk factors and structural remodel-
ing (6). In this study, we have found an additive
effect of cardiorespiratory ﬁtness over weight loss.
It is probable that common mechanisms contribute
to this synergistic effect of cardiorespiratory ﬁtness
on reduction of the AF burden. Regular exercise has
been shown to improve autonomic function (27), BP
(28), insulin sensitivity (29), vascular function (30),
and inﬂammation (31). In this study, we observed
beneﬁcial effects of cardiorespiratory ﬁtness gain on
BP, diabetic control, lipid proﬁle, and inﬂammation,
all of which may have contributed to reduced AF
burden. This results in a better outcome and
freedom from AF.
The strength of this study is that cardiorespiratory
ﬁtness was measured by a commonly performed,
highly reproducible, and well-validated test. The
relative and combined contributions of ﬁtness and
fatness to AF remain controversial, but our results
suggest that ﬁtness may partially offset the adverse
effects of body fatness. Evidently, the compounded
beneﬁt of “alliance of cardiorespiratory ﬁtness with
weight loss” is over and above the strategic gain
CENTRAL ILLUSTRATION Cardiorespiratory Fitness and AF Recurrence: CARDIO-FIT trial
Pathak, R.K. et al. J Am Coll Cardiol. 2015; 66(9):985–96.
AF ¼ atrial ﬁbrillation; BP ¼ blood pressure; CARDIO-FIT ¼ CARDIOrespiratory FITness; CRF ¼ cardiorespiratory ﬁtness; MET ¼ metabolic equivalent.
FIGURE 4 Outcomes of AF Freedom According to Cardiorespiratory Fitness Gain (<2 METs Gain vs. $2 METs Gain) and Weight Loss (<10% vs. $10% Weight Loss)
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(A) Kaplan-Meier curve for total AF-free survival (multiple ablation procedures  drugs) according to weight trend. (B) Kaplan-Meier curve for total AF-free survival
(multiple ablation procedures  drugs) according to weight ﬂuctuation. WL ¼ weight loss; other abbreviations as in Figure 1.
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PERSPECTIVES
COMPETENCY IN PATIENT CARE AND PROCEDURAL
SKILLS: Increased cardiorespiratory ﬁtness is synergistic with
weight loss as part of the management strategy for rhythm
control in overweight and obese patients with AF.
TRANSLATIONAL OUTLOOK: Additional studies are needed
to better understand the mechanism by which cardiorespiratory
ﬁtness reduces the risk of recurrent AF and to determine whether
particular regimens used to achieve or maintain ﬁtness are more
or less effective than others.
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995provided by each individually. These data highlight
the prognostic role for exercise testing in predicting AF
outcomes and importance of interventions to improve
physical activity and cardiorespiratory ﬁtness in
overweight and/or obese symptomatic AF patients.
STUDY LIMITATIONS. This study has the potential for
bias inherent in observational studies. However,
measurement bias has been reduced through stan-
dardized processes in our clinic and the evaluation
by operators blinded to the patients’ risk factor man-
agement regimens. AF burden assessment using 7-day
Holter may miss some AF episodes; however, it was
used for AF freedom assessment in both the groups
and was a limitation for all. Ascertainment bias was
reduced through the routine collection of outcome
data. Although there are clinical limitations of using
BMI as a surrogate measure of body fatness, this
was used because of its wide applicability, non-
invasiveness, and simple measure. Improvement in
individual risk factors for AF such as obesity, hyper-
tension, and DM is likely to vary between patients, but
the speciﬁc contribution of these risk factors in AF-
related outcomes is beyond the scope of this study.
CONCLUSIONS
Increased cardiorespiratory ﬁtness was associated
with a dose-dependent reduction in AF burden andmaintenance of sinus rhythm. Cardiorespiratory
ﬁtness gain provides a 12% incremental gain over
weight loss in long-term freedom from total AF
burden. This occurs in conjunction with favorable
changes in cardiometabolic risk factor proﬁle, in-
ﬂammatory state, and cardiac remodeling.
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